Latest Form 144 filings
Officers, directors and other affiliates of a company file Form 144 when they place an order to sell restricted or control shares, if they plan to sell more than 5,000 shares or more than $50,000 worth within three months. It is a notice of a planned sale; officers and directors report the sale itself later on Form 4. 13D, 13G and Form 144 explained
Form 144 notices
Newest first. When a Form 144/A amends a notice, only the amendment is listed.
Filed in the last 365 days (US Eastern dates).
Form 144 filings on Livermore: Jan 4, 2023 to Sep 29, 2026.
Notices with a clearly misreported market value are left out of this list and its totals; they still appear, flagged, on the company's page. A value counts as misreported when the price per share it implies is far above the company's prices in Form 4 trades and 13F filings around the planned sale date.
- Notices
- 24
- Market value to sell
- $85.6M
- Sellers
- 7
- Companies
- 1
- Under 10b5-1 plans
- 6
| Company | Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|---|
| PTGXProtagonist Therapeutics, Inc | Aug 10, 20264:49 PM ET | Dinesh PatelCEO | 225.0K | $33.6M | Aug 10, 202610b5-1 | J.P. Morgan Securities LLC | SEC |
| PTGXProtagonist Therapeutics, Inc | Jun 23, 20264:27 PM ET | William WaddillDirector | 9.00K | $1.04M | Jun 23, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | Jun 10, 20264:29 PM ET | William WaddillDirector | 9.00K | $952.8K | Jun 10, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | May 29, 20264:23 PM ET | William WaddillDirector | 9.00K | $903.7K | May 29, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | May 12, 20265:29 PM ET | Dinesh PatelCEO | 75.0K | $7.76M | May 12, 202610b5-1 | J.P. Morgan Securities LLC | SEC |
| PTGXProtagonist Therapeutics, Inc | May 8, 20264:23 PM ET | Bryan M & Courtney L Giraudo RTDirector | 11.1K | $1.11M | May 8, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | May 7, 20265:21 PM ET | Bryan GiraudoDirector | 36.0K | $3.60M | May 7, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | May 7, 20264:49 PM ET | Bryan M & Courtney L Giraudo RTDirector | 12.0K | $1.20M | May 7, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | Apr 21, 20264:57 PM ET | Asif AliOfficer | 1.75K | $184.6K | Apr 20, 2026 | Morgan Stanley Smith Barney Operations Department | SEC |
| PTGXProtagonist Therapeutics, Inc | Mar 26, 20264:05 PM ET | Harold SelickDirector | 24.0K | $2.52M | Mar 26, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | Mar 26, 20264:05 PM ET | Asif AliOfficer | 24.8K | $2.58M | Mar 26, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | Mar 26, 20264:01 PM ET | Arturo MolinaOfficer | 15.0K | $1.57M | Mar 26, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | Mar 24, 20265:56 PM ET | Dinesh PatelCEO | 54.7K | $5.39M | Mar 24, 2026 | J.P. Morgan Securities LLC | SEC |
| PTGXProtagonist Therapeutics, Inc | Feb 17, 20265:27 PM ET | Lewis T WilliamsDirector | 18.0K | $1.48M | Feb 17, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | Feb 6, 20264:04 PM ET | William D WaddillDirector | 20.0K | $1.67M | Feb 6, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | Jan 27, 20265:12 PM ET | Asif AliOfficer | 46.2K | $3.84M | Jan 27, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | Jan 27, 20264:01 PM ET | Arturo MolinaOfficer | 5.00K | $410.0K | Jan 27, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | Jan 26, 20264:29 PM ET | Arturo MolinaOfficer | 5.00K | $411.4K | Jan 26, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | Jan 23, 20264:32 PM ET | Arturo MolinaOfficer | 13.2K | $1.10M | Jan 23, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTGXProtagonist Therapeutics, Inc | Jan 23, 20264:06 PM ET | Dinesh PatelCEO | 108.3K | $9.16M | Jan 23, 2026 | J.P. Morgan Securities LLC | SEC |
| PTGXProtagonist Therapeutics, Inc | Jan 21, 20265:12 PM ET | Arturo Molina MDOfficer | 9.51K | $784.7K | Jan 20, 2026 | Morgan Stanley Smith Barney Operations Department | SEC |
| PTGXProtagonist Therapeutics, Inc | Jan 21, 20265:11 PM ET | Dinesh V Patel PH DOfficer, Director | 34.4K | $2.84M | Jan 20, 2026 | Morgan Stanley Smith Barney Operations Department | SEC |
| PTGXProtagonist Therapeutics, Inc | Jan 21, 20265:10 PM ET | Asif AliOfficer | 8.59K | $708.3K | Jan 20, 2026 | Morgan Stanley Smith Barney Operations Department | SEC |
| PTGXProtagonist Therapeutics, Inc | Oct 10, 20254:18 PM ET | William WaddillDirector | 12.0K | $804.5K | Oct 10, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |